Problem: Glooma is addressing the critical problem of inadequate early detection of breast cancer, which remains one of the leading causes of cancer-related deaths among women. Traditional breast self-examinations are often inconsistent, inaccurate, and difficult for many women to perform correctly, leading to late-stage diagnoses when treatment options are limited, and survival rates are lower. Many women lack confidence in their ability to detect abnormalities, forget to perform regular self-exams, or are unsure of the correct technique. This results in a significant number of breast cancer cases being detected too late, when the disease has already progressed.

Solution: Glooma's solution to the problem of inadequate early detection of breast cancer is the SenseGlove, an innovative, home-based medical device designed to empower women with accurate and reliable breast self-examinations. The SenseGlove is equipped with pressure sensors and together with AI and a mobile app that guides users through the self-exam process, detects abnormalities in breast tissue, and monitors changes over time. The app provides clear, actionable insights and reminders for regular exams, helping women to identify potential issues early and seek medical attention sooner. By making breast health monitoring accessible, easy, and effective, Glooma's SenseGlove aims to improve early detection rates, reduce late-stage diagnoses, and ultimately save lives.

USP: The SenseGlove offers a reliable, accurate, and easy-to-use solution for at-home breast self-examinations, made for all women to empower them to confidently take control of their health. This personalized and proactive approach to breast health sets Glooma apart, making early detection accessible and effective, ultimately saving lives.